[1] |
Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care, 2004,27(7):1584-1590. doi: 10.2337/diacare.27.7.1584.
doi: 10.2337/diacare.27.7.1584
URL
pmid: 15220232
|
[2] |
Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med, 2008,5(7):e152. doi: 10.1371/journal.pmed.0050152.
doi: 10.1371/journal.pmed.0050152
URL
pmid: 18630984
|
[3] |
Wu Z, Guo J, Huang Y, et al. Diabetes mellitus in patients with pulmonary tuberculosis in an aging population in Shanghai, China: Prevalence, clinical characteristics and outcomes. J Diabetes Complications, 2016,30(2):237-241. doi: 10.1016/j.jdiacomp.2015.11.014.
doi: 10.1016/j.jdiacomp.2015.11.014
URL
pmid: 26684166
|
[4] |
Wang XH, Ma AG, Han XX, et al. Relationship between Toll-like receptor 4 and type-2 diabetes mellitus complicated by tuberculosis. Int J Tuberc Lung Dis, 2017,21(8):910-915. doi: 10.5588/ijtld.17.0096.
doi: 10.5588/ijtld.17.0096
URL
pmid: 29073942
|
[5] |
Zhang Q, Xiao HP, Cui HY, et al. Significant increase in natural-killer T cells in patients with tuberculosis complicated by type 2 diabetes mellitus. J Int Med Res, 2011,39(1):105-111. doi: 10.1177/147323001103900113.
doi: 10.1177/147323001103900113
URL
pmid: 21672313
|
[6] |
Pal R, Ansari MA, Hameed S, et al. Diabetes Mellitus as Hub for Tuberculosis Infection: A Snapshot. Int J Chronic Dis, 2016,2016:5981574. doi: 10.1155/2016/5981574.
doi: 10.1155/2016/5981574
URL
pmid: 27819024
|
[7] |
American Diabetes Association. Standards of Medical Care in Diabetes--2010. Diabetes Care, 2010,33(Suppl 1):S11-S61. doi: 10.2337/dc10-S011.
doi: 10.2337/dc10-S011
URL
|
[8] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断.2017-11-09.
|
[9] |
Rao S. Tuberculosis and patient gender: An analysis and its implications in tuberculosis control. Lung India, 2009,26(2):46-47. doi: 10.4103/0970-2113.48897.
doi: 10.4103/0970-2113.48897
URL
pmid: 20440394
|
[10] |
周晴, 胡良安. 肺结核合并糖尿病的研究进展. 国际呼吸杂志, 2016,36(14):1098-1101. doi: 10.3760/cma.j.issn.1673-436X.2016.14.014.
|
[11] |
Vrieling F, Ronacher K, Kleynhans L, et al. Patients with Concurrent Tuberculosis and Diabetes Have a Pro-Atherogenic Plasma Lipid Profile. EBio Medicine, 2018,32:192-200. doi: 10.1016/j.ebiom.2018.05.011.
|
[12] |
Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest, 2001,108(1):15-23. doi: 10.1172/JCI13416.
doi: 10.1172/JCI13416
URL
pmid: 11435451
|
[13] |
Denisenko YK, Lobanova EG, Novgorodtseva TP, et al. The Role of Arachidonic Acid Metabolites (Endocannabinoids and Eicosanoids) in the Immune Processes: A Review. International Journal of Chemical and Biomedical Science, 2015,1(3):70-78.
|
[14] |
Abakay O, Abakay A, Sen HS, et al. The relationship between inflammatory marker levels and pulmonary tuberculosis severity. Inflammation, 2015,38(2):691-696. doi: 10.1007/s10753-014-9978-y.
doi: 10.1007/s10753-014-9978-y
URL
pmid: 25028104
|
[15] |
Zhong L, Zhou J, Chen X, et al. Serum metabolomic study for the detection of candidate biomarkers of tuberculosis. Int J Clin Exp Pathol, 2016,9(3):3256-3266.
|
[16] |
Rangel Moreno J, Estrada García I, De La Luz García Hernández M, et al. The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology, 2002,106(2):257-266. doi: 10.1046/j.1365-2567.2002.01403.x.
doi: 10.1046/j.1365-2567.2002.01403.x
URL
pmid: 12047755
|
[17] |
Stevenson CR, Critchley JA, Forouhi NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health. Chronic Illn, 2007,3(3):228-245. doi: 10.1177/17423953 07081502.
doi: 10.1177/1742395307081502
URL
pmid: 18083679
|
[18] |
Cooper AM, Khader SA. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev, 2008,226:191-204. doi: 10.1111/j.1600-065X.2008.00702.x.
doi: 10.1111/j.1600-065X.2008.00702.x
URL
pmid: 19161425
|
[19] |
Cooper AM, Magram J, Ferrante J, et al. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med, 1997,186(1):39-45. doi: 10.1084/jem.186.1.39.
doi: 10.1084/jem.186.1.39
URL
pmid: 9206995
|
[20] |
Shu CC, Wu MF, Hsu CL, et al. Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction. BMC Infect Dis, 2013,13:45. doi: 10.1186/1471-2334-13-45.
doi: 10.1186/1471-2334-13-45
URL
pmid: 23356448
|
[21] |
Peres CM, de Paula L, Medeiros AI, et al. Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis. Microbes Infect, 2007,9(4):483-489.
doi: 10.1016/j.micinf.2007.01.006
URL
|
[22] |
王静, 赵青, 冯国栋, 等. 白三烯B4在结核性脑膜炎患者脑脊液中的水平及临床意义. 细胞与分子免疫学杂志, 2015,31(8):1108-1111.
|
[23] |
Peres-Buzalaf C, de Paula L, Frantz FG, et al. Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins. Prostaglandins Leukot Essent Fatty Acids, 2011,85(2):75-81. doi: 10.1016/j.plefa.2011.04.024.
doi: 10.1016/j.plefa.2011.04.024
URL
pmid: 21621991
|
[24] |
Lu Y, Wang Y, Ong CN, et al. Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS. Diabetologia, 2016,59(11):2349-2359. doi: 10.1007/s00125-016-4069-2.
doi: 10.1007/s00125-016-4069-2
URL
pmid: 27514531
|